Cargando…
Is there any revival of the use of plasma therapy or neutralizing convalescent antibody therapy to treat SARS-CoV-2 variants and are we rethinking preparedness plans?
Autores principales: | Garraud, Olivier, Watier, Hervé |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164650/ https://www.ncbi.nlm.nih.gov/pubmed/37169698 http://dx.doi.org/10.1016/j.transci.2023.103726 |
Ejemplares similares
-
We need to rethink production technology for meat-packers—the old cutting table is being revived
por: Hinrichsen, Lars L, et al.
Publicado: (2022) -
Earlier the better: convalescent plasma
por: Tobian, Aaron A.R., et al.
Publicado: (2020) -
Convalescent plasma to treat COVID-19
por: Bloch, Evan M.
Publicado: (2020) -
A look-back at convalescent plasma to treat COVID-19
por: Garraud, Olivier, et al.
Publicado: (2021) -
Rethinking the INN system for therapeutic antibodies
por: Pottier, Jérémy, et al.
Publicado: (2016)